250 related articles for article (PubMed ID: 20331379)
1. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model.
Martinez LR; Mihu MR; Tar M; Cordero RJ; Han G; Friedman AJ; Friedman JM; Nosanchuk JD
J Infect Dis; 2010 May; 201(9):1436-40. PubMed ID: 20331379
[TBL] [Abstract][Full Text] [Related]
2. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
[TBL] [Abstract][Full Text] [Related]
3. In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections.
Cobrado L; Silva-Dias A; Azevedo MM; Pina-Vaz C; Rodrigues AG
J Antimicrob Chemother; 2013 Jan; 68(1):126-30. PubMed ID: 22991425
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
Vande Velde G; Kucharíková S; Van Dijck P; Himmelreich U
Int J Antimicrob Agents; 2018 Jul; 52(1):42-51. PubMed ID: 29572043
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.
Basas J; Palau M; Gomis X; Almirante B; Gavaldà J
PLoS One; 2019; 14(2):e0212426. PubMed ID: 30779771
[TBL] [Abstract][Full Text] [Related]
8. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
[No Abstract] [Full Text] [Related]
10. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
11. Antifungal lock therapy.
Walraven CJ; Lee SA
Antimicrob Agents Chemother; 2013 Jan; 57(1):1-8. PubMed ID: 23070153
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.
Andes D; Nett J; Oschel P; Albrecht R; Marchillo K; Pitula A
Infect Immun; 2004 Oct; 72(10):6023-31. PubMed ID: 15385506
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species.
Silva-Dias A; Miranda IM; Branco J; Cobrado L; Monteiro-Soares M; Pina-Vaz C; Rodrigues AG
J Antimicrob Chemother; 2015 Apr; 70(4):1083-93. PubMed ID: 25558078
[TBL] [Abstract][Full Text] [Related]
14. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.
Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K
J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120
[TBL] [Abstract][Full Text] [Related]
15. In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells.
Miceli MH; Bernardo SM; Ku TS; Walraven C; Lee SA
Antimicrob Agents Chemother; 2012 Jan; 56(1):148-53. PubMed ID: 21986822
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ferulic acid encapsulated chitosan nanoparticles against Candida albicans biofilm.
Panwar R; Pemmaraju SC; Sharma AK; Pruthi V
Microb Pathog; 2016 Jun; 95():21-31. PubMed ID: 26930164
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
Mukherjee PK; Long L; Kim HG; Ghannoum MA
Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
Cateau E; Rodier MH; Imbert C
J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
[TBL] [Abstract][Full Text] [Related]
19. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
Nieminen MT; Novak-Frazer L; Rautemaa V; Rajendran R; Sorsa T; Ramage G; Bowyer P; Rautemaa R
PLoS One; 2014; 9(5):e97864. PubMed ID: 24867320
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
